![Parkinson's disease: Levodopa‐induced dyskinesia and signal transduction - Santini - 2008 - The FEBS Journal - Wiley Online Library Parkinson's disease: Levodopa‐induced dyskinesia and signal transduction - Santini - 2008 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/a5e07edb-b55b-47f7-8e35-0188070bb2ee/febs_6296_f1.gif)
Parkinson's disease: Levodopa‐induced dyskinesia and signal transduction - Santini - 2008 - The FEBS Journal - Wiley Online Library
Differential Dopamine Receptor Occupancy Underlies L-DOPA-Induced Dyskinesia in a Rat Model of Parkinson's Disease | PLOS ONE
Concomitant shortâ•' and longâ•'duration response to levodopa in the 6â•'OHDAâ•'lesioned rat: a behavioural
Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease | PLOS ONE
![Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats. - Abstract - Europe PMC Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4323744/bin/nihms647533f2.jpg)
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats. - Abstract - Europe PMC
![Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease | SpringerLink Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40263-014-0205-z/MediaObjects/40263_2014_205_Fig1_HTML.gif)
Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease | SpringerLink
![Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa | PNAS Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa | PNAS](https://www.pnas.org/cms/10.1073/pnas.94.7.3363/asset/0d0fa8dc-c619-4ba6-b6b1-a9e52590f891/assets/graphic/pq0773933002.jpeg)
Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa | PNAS
![Differential Expression of Striatal ΔFosB mRNA and FosB mRNA After Different Levodopa Treatment Regimens in a Rat Model of Parkinson's Disease | SpringerLink Differential Expression of Striatal ΔFosB mRNA and FosB mRNA After Different Levodopa Treatment Regimens in a Rat Model of Parkinson's Disease | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12640-018-9993-0/MediaObjects/12640_2018_9993_Fig4_HTML.png)
Differential Expression of Striatal ΔFosB mRNA and FosB mRNA After Different Levodopa Treatment Regimens in a Rat Model of Parkinson's Disease | SpringerLink
Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease | PLOS ONE
![Biomolecules | Free Full-Text | Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease | HTML Biomolecules | Free Full-Text | Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease | HTML](https://www.mdpi.com/biomolecules/biomolecules-09-00142/article_deploy/html/images/biomolecules-09-00142-g002.png)
Biomolecules | Free Full-Text | Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease | HTML
![Biomolecules | Free Full-Text | Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease | HTML Biomolecules | Free Full-Text | Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease | HTML](https://www.mdpi.com/biomolecules/biomolecules-12-00243/article_deploy/html/images/biomolecules-12-00243-g001.png)
Biomolecules | Free Full-Text | Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease | HTML
![Biomolecules | Free Full-Text | Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease | HTML Biomolecules | Free Full-Text | Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease | HTML](https://www.mdpi.com/biomolecules/biomolecules-09-00142/article_deploy/html/images/biomolecules-09-00142-g001.png)
Biomolecules | Free Full-Text | Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease | HTML
Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease | PLOS ONE
![Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap - The Lancet Neurology Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap - The Lancet Neurology](https://www.thelancet.com/cms/attachment/dc81efda-02b5-4c79-b6fa-e486f08108e5/gr1_lrg.jpg)
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap - The Lancet Neurology
Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease | PLOS ONE
![Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap - ScienceDirect Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1474442210702180-gr3.jpg)
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap - ScienceDirect
![Concomitant short‐ and long‐duration response to levodopa in the 6‐OHDA‐lesioned rat: a behavioural and molecular study - Marin - 2007 - European Journal of Neuroscience - Wiley Online Library Concomitant short‐ and long‐duration response to levodopa in the 6‐OHDA‐lesioned rat: a behavioural and molecular study - Marin - 2007 - European Journal of Neuroscience - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b1e3e8a6-036e-48b1-930e-d6bb56e5eb7d/ejn_5265_f4.gif)